<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03507335</url>
  </required_header>
  <id_info>
    <org_study_id>KUH507E015</org_study_id>
    <nct_id>NCT03507335</nct_id>
  </id_info>
  <brief_title>Novel Methods for Arrhythmia Detection</brief_title>
  <official_title>Novel Methods for Arrhythmia Detection: Chest Strap and PPG-device Compared to Holter-device for Atrial Fibrillation Detection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims Approximately 20-25% of strokes are of cardioembolic origin, atrial fibrillation (AF)
      being a significant cause of cardioembolic strokes. AF is often symptomless and intermittent,
      making its detection a clinical challenge. Currently the golden standard for diagnosis of AF
      is by 12-lead electrocardiogram (ECG) or any other ECG-strip.

      The primary aim of the study is to assess the potential of chest strap as an ECG monitor
      especially in arrhythmia detection by cardiologist and algorithm. The secondary aim is to
      assess potential of photoplethysmography (PPG) based device for arrhythmia detection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design:

      Study design will be a prospective case-control study at Kuopio University Hospital (KUH) in
      Finland. Study material will be collected in internal medicine emergency department at KUH.
      The study design was approved by University of Eastern Finland ethics committee (237/2017).

      Study participants will receive a written information sheet about the study and will be
      provided with an opportunity to ask questions concerning the study. A written informed
      consent will be signed by the participants, including a permission to use patient's medical
      records.

      Screening of study participants will be made in participating hospitals from admitted
      patients in January - May 2018. The inclusion criteria for study group patients was atrial
      fibrillation confirmed by a doctor-interpreted 12-lead ECG . Exclusion criteria were: body
      mass index (BMI) over 35; implanted pacemaker device; 12-lead ECG findings of left bundle
      branch block (LBBB) or right bundle branch block (RBBB); medical condition requiring
      immediate treatment that would be delayed by the study measurements; serious infectious
      disease. Control group consisted of patients with normal sinus rhythm (SR) in 12-lead ECG.

      Measurement

      Demographics of study patients, including age, gender, previous medical history (as reported
      by patient or from patient medical records), length and weight , will be recorded.

      Before measurements, the patient will be asked to rest for at least 2 minutes, and lay still
      during the measurements. First, a 12-lead ECG will taken over a period of 10 seconds for
      rhythm confirmation for study grouping. In the next step, altogether 5 wet electrodes will be
      attached to patient to record ECG with Faros 360 Holter device (Mega Elektroniikka, Kuopio,
      Finland) to be used as golden standard for rhythm monitoring. Simultaneously a heart rate
      monitoring chest strap (Suunto Movesense, Suunto, Vantaa, Finland) will applied to chest
      approximately 2 cm below the lower end of sternum, according to manufacturer's instructions.
      PPG-device (Empatica Empatica ltd, Milan, Italy) will be connected to non-dominating wrist. A
      total of 24 hous recording will be made. The data from heart rate chest strap will sent via
      Bluetooth connection to study computer; the data from Faros Holter device was recorded to
      device´s internal memory card and transferred to analyzing software. The data collected was
      anonymized and ECG data from chest strap and Holter device was analyzed using MATLAB
      software.

      The quality of the ECG-strip will be defined as good (no or only minor artefacts), average
      (artefacts but QRS complex and/or P-wave identifiable) or poor (major artefacts, no
      identifiable QRS complex and/or P-wave) by the cardiologist. The rhythm from the ECG-strips
      was divided to three categories: sinus rhythm, atrial fibrillation or other/inconclusive. The
      cardiologists also assessed the possibility to detect P-waves from the ECG-strips with SR
      (yes/no).

      The study population will consisted of total 100 patients. According to the initial 12-lead
      ECG, total 50 patients with atrial fibrillation will be collected, and control group will
      consist of 50 patients with normal sinus rhythm.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2018</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Data quality</measure>
    <time_frame>24 hours</time_frame>
    <description>Data quality from Faros 360 Holter device (Mega Elektroniikka, Kuopio, Finland), chest strap (Suunto Movesense, Suunto, Vantaa, Finland) and PPG-device (Empatica Empatica ltd, Milan, Italy) during 24 hours. Scale 1-4 (1 = Good, 2 = Average, 3 = Poor, 4 = Indecisive).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Data quality to enable arrhythmia diagnosis</measure>
    <time_frame>24 hours</time_frame>
    <description>Data quality from Faros Holter device (Mega Elektroniikka, Kuopio, Finland), chest strap (Suunto Movesense, Suunto, Vantaa, Finland) and PPG-device (Empatica Empatica ltd., Milan, Italy) to enable arrhythmia diagnosis by cardiologist or algorithm. Scale 1-4 (1 = Good, 2 = Average, 3 = Poor, 4 = Indecisive).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Arrhythmia Atrial</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Atrial fibrillation</arm_group_label>
    <description>Patients with atrial fibrillation during measurements</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sinus</arm_group_label>
    <description>Patients with sinus rhythm during measurements</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>chest strap and PPG-device for monitoring the rhythm</intervention_name>
    <description>chest strap and PPG-device for monitoring the rhythm during 24 hours for both groups (atrial fibrillation and sinus)</description>
    <arm_group_label>Atrial fibrillation</arm_group_label>
    <arm_group_label>Sinus</arm_group_label>
    <other_name>Suunto Movesense, Suunto, Vantaa, Finland</other_name>
    <other_name>Empatica Empatica ltd, Milan, Italy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study material will be collected in internal medicine emergency department of KUH
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Atrial fibrillation in 12-lead ECG and admission to hospital (n=50) Sinus rhythm in 12-lead
        ECG and admission to hospital (n=50)

        Exclusion Criteria:

          -  BMI&gt;35

          -  LBBB

          -  RBBB

          -  medical condition requiring immediate treatment

          -  serious infectious disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tero Martikainen, PhD</last_name>
    <phone>+358447175045</phone>
    <email>tero.martikainen@kuh.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helena Jäntti, PhD</last_name>
    <phone>+358447174881</phone>
    <email>helena.jantti@kuh.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <state>East-Finland</state>
        <zip>70029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tero J Martikainen, PhD</last_name>
      <phone>+358447175045</phone>
      <email>tero.martikainen@kuh.fi</email>
    </contact>
    <contact_backup>
      <last_name>Helena Jäntti, PhD</last_name>
      <phone>+358447174881</phone>
      <email>helena.jantti@kuh.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016 Nov;18(11):1609-1678. Epub 2016 Aug 27.</citation>
    <PMID>27567465</PMID>
  </reference>
  <reference>
    <citation>Nemati S, Ghassemi MM, Ambai V, Isakadze N, Levantsevych O, Shah A, Clifford GD. Monitoring and detecting atrial fibrillation using wearable technology. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3394-3397. doi: 10.1109/EMBC.2016.7591456.</citation>
    <PMID>28269032</PMID>
  </reference>
  <reference>
    <citation>Thijs V. Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke. Stroke. 2017 Oct;48(10):2671-2677. doi: 10.1161/STROKEAHA.117.017083. Epub 2017 Sep 15. Review.</citation>
    <PMID>28916671</PMID>
  </reference>
  <reference>
    <citation>Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J, Varma N, Glotz de Lima G, Kalman J, Claes N, Lobban T, Lane D, Lip GYH, Boriani G; ESC Scientific Document Group. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Europace. 2017 Oct 1;19(10):1589-1623. doi: 10.1093/europace/eux177.</citation>
    <PMID>29048522</PMID>
  </reference>
  <results_reference>
    <citation>Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.</citation>
    <PMID>28483832</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Tero Martikainen</investigator_full_name>
    <investigator_title>Chief physician</investigator_title>
  </responsible_party>
  <keyword>Arrhythmia Atrial</keyword>
  <keyword>heart rate monitoring</keyword>
  <keyword>stroke</keyword>
  <keyword>atrial fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

